ClinicalTrials.govpublic full text
CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy
b-cell leukemia, b-cell lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 140982
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.